Familial partial lipodystrophy type Köbberling
Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
Age of Onset
Autosomal dominant ?A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease
Autosomal recessive ?Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype
X-linked dominant ?X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked recessive ?Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder
Mitochondrial or multigenic ?Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor ?Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Other Names (AKA)
Familial partial lipodystrophy type 1; FPLD1; Familial partial lipodystrophy, Köbberling type
Congenital and Genetic Diseases; Endocrine Diseases; Skin Diseases
This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.
|Medical Terms||Other Names||
|80%-99% of people have these symptoms|
Body fails to respond to insulin
Loss of fat tissue in localized area
|30%-79% of people have these symptoms|
Fatty infiltration of liver
[ more ]
Yellow bumps of fatty deposits on skin
|5%-29% of people have these symptoms|
Darkened and thickened skin
|Coronary artery atherosclerosis||
Plaque build-up in arteries supplying blood to heart
|Percent of people who have these symptoms is not available through HPO|
|Abnormality of the musculature||
Acute pancreatic inflammation
High blood sugar
Increased plasma triglycerides
Increased serum triglycerides
[ more ]
Increased fat around the neck
|Increased facial adipose tissue||
Increased amount of facial fat
|Increased subcutaneous truncal adipose tissue||
Increased fat below the skin in trunk
|Insulin-resistant diabetes mellitus||
Insulin resistant diabetes
[ more ]
Signs and symptoms begin before 15 years of age
Inability to make and keep healthy fat tissue
|Loss of gluteal subcutaneous adipose tissue||
Loss of fat tissue below the skin in gluts
|Loss of subcutaneous adipose tissue in limbs||
Loss of fat tissue below the skin in limbs
|Prominent superficial veins||
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- Familial Partial Lipodystrophy. NORD. 2015; https://rarediseases.org/rare-diseases/familial-partial-lipodystrophy/.
- Mantzoros C. Lipodystrophic syndromes. UpToDate. July 27, 2015; https://www.uptodate.com/contents/lipodystrophic-syndromes.
- Guillín-Amarelle C. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome. Endocrine. July 30, 2016; https://www.ncbi.nlm.nih.gov/pubmed/27473102.
- Handelsman Y & cols. The Clinical Apporach to the Detection of Lipodystrophy An AACE Consensus Statement. Endocrine practice?: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2013; 19(1):107-116. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108221/.